TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial
This study aims to determine if TS prophylaxis benefits HIV-infected Malawian adults after a good response to ART. If TS prophylaxis does indeed show benefit, it is important to determine if this is due to its antibacterial and/or antimalarial properties.
Methods/design
A randomized, controlled, open-label, phase III trial of continued standard of care prophylaxis with daily trimethoprim-sulfamethoxazole (TS) compared to discontinuation of standard of care TS prophylaxis and starting weekly chloroquine (CQ) prophylaxis or discontinuation ...
Source: Trials - July 17, 2016 Category: Research Source Type: clinical trials
Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma; InfectionInterventions: Drug: Standard myeloma treatment; Drug: Clarithromycin; Drug: Sulfamethoxazole/trimethoprim; Drug: ObservationSponsors: Henrik Gregersen; Danish Myeloma Study GroupRecruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2015 Category: Research Source Type: clinical trials
Sulfamethoxazole for the Treatment of Primary PREPL Deficiency
Conditions: Hypotonia Cystinuria Syndrome; Isolated PREPL DeficiencyIntervention: Drug: SulfamethoxazoleSponsors: Universitair Ziekenhuis Brussel; Katholieke Universiteit LeuvenEnrolling by invitation - verified October 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 7, 2015 Category: Research Source Type: clinical trials
